ÂÜÀòÂÒÂ×

Nikhilesh Chand is an accomplished professional in the healthcare and investment sectors, currently serving as a Senior Director at Patient Square Capital since July 2024. Prior experience includes roles as Chief Strategy Officer in Residence and Senior Vice President of M&A at BridgeBio from January 2020 to July 2024, and as an Analyst for healthcare investments at Viking Global Investors from March 2016 to December 2019. Nikhilesh's earlier career involved market analysis and strategy at Genentech and consulting at The Boston Consulting Group, focusing on high-impact healthcare projects. Nikhilesh holds a PhD in Biochemistry from Harvard University, where extensive research resulted in multiple publications and participation in international conferences, alongside roles in student leadership and community initiatives at Harvard. Nikhilesh's educational background also includes a master's degree from the University of Cambridge and an undergraduate degree in Chemistry from St. Stephen's College, Delhi.